Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) has been assigned an average recommendation of “Hold” from the six brokerages that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has given a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $6,032.50.
RBGLY has been the subject of several recent research reports. Sanford C. Bernstein raised Reckitt Benckiser Group from a “market perform” rating to an “outperform” rating in a research report on Monday, December 11th. Jefferies Financial Group lowered Reckitt Benckiser Group from a “hold” rating to an “underperform” rating in a research note on Monday, December 11th. Finally, BNP Paribas upgraded Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a research note on Tuesday, January 9th.
Get Our Latest Research Report on Reckitt Benckiser Group
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group Increases Dividend
The business also recently announced a dividend, which will be paid on Monday, June 3rd. Shareholders of record on Friday, April 12th will be issued a dividend of $0.2701 per share. The ex-dividend date of this dividend is Thursday, April 11th. This is an increase from Reckitt Benckiser Group’s previous dividend of $0.18.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- Breakout Stocks: What They Are and How to Identify Them
- 3 Stocks With Unusual Call Option Activity
- What Are Growth Stocks and Investing in Them
- Trump Media & Technology Group Soars on Market Debut
- 5 Top Rated Dividend Stocks to Consider
- 3 Stocks Insiders Are Buying That Analysts Love
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.